Skip to content
Axe Capital logo Axe Capital Trading News

This AI Stock Is Trading Near Record Highs. Is It Too Late to Buy?

2026-10-01 19:26 •Anders Bylund •The Motley Fool Positive Axe Cap view: Selective •Equities•Earnings•Technology•AI•Semiconductors •APH•GLW•FLEX•LFUS•CGNX

Axe Cap view

Is Now the Time to Buy Amphenol Near Its Peak?

Amphenol’s strong AI-driven growth is impressive, but the share price is testing patience.

Amphenol, a key player in AI infrastructure hardware, has posted impressive results with 55% sales growth and a book-to-bill ratio above 1, signaling solid demand ahead. Yet it’s trading close to all-time highs after a massive three-year rally exceeding 300%. The better margin profile compared to peers like Corning and Cognex is a strength. But the overall semiconductor equipment space, though vital, can see sharp swings and profit-taking. For South African investors, that means watching USD/ZAR closely—any rand weakness might add inflationary pressure on imported tech stocks, indirectly affecting appetite for such shares. Unlike local blue chips such as Naspers or Prosus, which offer AI exposure through software, Amphenol’s hardware focus is more niche and US-centric. If US dollar strength fades or AI spending cools, the high valuation could quickly come under strain. That said, the Q3 guidance looks promising, so the momentum might still run. this is just our opinion and not financial advice

How I would invest

Wait for a pullback before buying Amphenol, preferably when USD/ZAR stabilizes near 18.5 or below. Local AI-exposed stocks like Naspers remain a better entry point for risk-sensitive investors.

What I would watch
  • APH
  • USD/ZAR
  • Naspers
What could go wrong
  • US dollar weakening reducing appeal of US-listed tech hardware
  • AI sector hype fading and resulting in share price correction
How strongly I feel

6/10

Amphenol, a maker of connectors and cables for AI infrastructure, is trading near all-time highs with strong fundamentals. Despite a 311.6% three-year gain, the company's Q2 results show 55% sales growth, 67% EPS growth, and a healthy book-to-bill ratio of 1.23, suggesting continued momentum. While the stock has underperformed peers this year, recent quarterly trends favor Amphenol, and analysts suggest the next leg of growth may still be ahead.

Our take is based on reporting first published by The Motley Fool.

Read the original story